Get started
GoldenCrowley

$AKBA Therapeutics $1.25 is already programmed - Long/Call

Long
Akebia Therapeutics, Inc. (NASDAQ:AKBA)  
GoldenCrowley  
NASDAQ:AKBA   Akebia Therapeutics, Inc.
Fundamental Analysis
3
1
fundamental
Fully expect a good earnings report. Positive news from the company. Nothing but good news as far as this company is concerned. Earnings posting this week, and will not disappoint. We could see a nice jump up here.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.